Pediapharm Announces Extension of Debentures and Warrants

Pediapharm (TSXV:PDP) has proposed to amend its existing convertible secured debentures and common share purchase warrants issued on March 30, 2015 with a maturity date of March 30, 2019.
As quoted in the press release:

The Company expects to enter into agreements with all of the Holders, representing an aggregate of $5,500,000 of Debentures. Any such extensions that are not approved by the individual Holders will remain subject to the original terms of the Debentures and shall mature on the Original Maturity Date.

Click here to read the full press release.